M
Madrigal Pharmaceuticals, Inc. (MDGL)
NMS – Real vaqt narxi. Valyuta: USD
510.26
+13.23 (2.66%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
510.26
+13.23 (2.66%)
Yopilishda: May 12, 2026, 4:00 PM EDT
This stock has a consensus price target of $607.24 based on the ratings of 19 analysts. The high is $964.00 and the low is $382.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 382 | $ 607.24 | $ 964 |
| O’zgarish | -23.14% | 22.17% | 93.95% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-05-07 | 13.28% | Canaccord Genuity | $587 → $578 | Maintains | Buy |
| 2026-05-07 | 27.19% | Evercore ISI Group | $652 → $649 | Maintains | Outperform |
| 2026-05-06 | 21.51% | HC Wainwright & Co. | $620 → $620 | Reiterates | Buy |
| 2026-02-20 | 3.67% | B of A Securities | $570 → $529 | Maintains | Neutral |
| 2026-01-28 | 88.92% | Barclays | $964 | Initiates Coverage On | Overweight |